Author details

Full Name

Katja von Hoff

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36786841	Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
36356895	Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.	Eur J Med Genet	2023
36437415	Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
37287693	A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial <i>ZFTA-</i>fused ependymoma.	Neurooncol Adv	2023
36715306	Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.	Neuro Oncol	2023
37073482	Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy.		2023
37379234	Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.	Neuro Oncol	2023
36459208	Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.	Acta Neuropathol	2023
35151105	Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial.	Eur J Cancer	2022
36137663	MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.	AJNR Am J Neuroradiol	2022
36137662	Imaging Characteristics of CNS Neuroblastoma-<i>FOXR2</i>: A Retrospective and Multi-Institutional Description of 25 Cases.	AJNR Am J Neuroradiol	2022
35728810	Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS-mutant neurocutaneous melanosis.	Neuropathol Appl Neurobiol	2022
35664557	Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data.	Neurooncol Adv	2022
33908610	Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.	Neuro Oncol	2022
35190934	Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.	J Neurooncol	2022
34417833	PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.	Acta Neuropathol	2021
34077956	Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.	Neuro Oncol	2021
33331885	Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study.	Neuro Oncol	2021
32514758	CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort.	Acta Neuropathol	2020
31971950	Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.	PLoS One	2020
31768671	Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.	Acta Neuropathol	2020
31867747	Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.	Neuropathol Appl Neurobiol	2020
32383815	A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.	Pediatr Blood Cancer	2020
32330099	Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.	J Clin Oncol	2020
32601913	ETMR: a tumor entity in its infancy.	Acta Neuropathol	2020
33305077	Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial.	Adv Radiat Oncol	2020
30850560	Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.	Oncologist	2019
31802000	The molecular landscape of ETMR at diagnosis and relapse.	Nature	2019
31727173	Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort.	Acta Neuropathol Commun	2019
30027327	MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.	Clin Neuroradiol	2019
29539639	DNA methylation-based classification of central nervous system tumours.	Nature	2018
30102236	Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group.	Lancet Oncol	2018
29489754	The landscape of genomic alterations across childhood cancers.	Nature	2018
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	2018
28168833	Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.	Am J Med Genet A	2017
28892064	A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.	Nat Med	2017
31385949	Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.	Neurooncol Pract	2017
28011926	Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.	Neuro Oncol	2017
27858204	The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.	Acta Neuropathol	2017
27863192	Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.	J Clin Oncol	2016
27423645	Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.	J Neurooncol	2016
26919435	New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.	Cell	2016
27269943	Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.	J Clin Oncol	2016
27040285	Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.	Acta Neuropathol	2016
26774521	Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'.	Eur J Cancer	2016
26608522	Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature.	J Neurooncol	2016
27539613	Evidence of H3 K27M mutations in posterior fossa ependymomas.	Acta Neuropathol	2016
24894640	Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.	Neuropathol Appl Neurobiol	2015
25916887	Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified.	Neuro Oncol	2015
25617910	Neuropsychological short assessment of disease- and treatment-related intelligence deficits in children with brain tumours.	Eur J Paediatr Neurol	2015